{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-26-000577","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2026-03-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.898777+00:00","generated_at":"2026-05-15T08:07:45.076246+00:00","sec_items":["1.03","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":1.0,"confidence":"high","headline":"Lipella Pharmaceuticals files Chapter 11 bankruptcy, plans 363 sale process","bullets":["Filed voluntary Chapter 11 petition in Western District of Pennsylvania on March 30, 2026.","Company intends to pursue a 363 sale process to maximize value for creditors.","Seeks customary first-day relief to continue operations, including payroll and cash management.","Company cautions trading in common stock is highly speculative and may not reflect recovery for holders."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-26-000577","json":"https://secwatch.observer/filing/0001753926-26-000577.json","markdown":"https://secwatch.observer/filing/0001753926-26-000577.md","text":"https://secwatch.observer/filing/0001753926-26-000577.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392626000577/0001753926-26-000577-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392626000577/g085465_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:07:45.076246+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}